Recent lateral moves raise a bigger question for full-service firms – can patent litigation remain a strategic priority when competing practices generate larger profits?
As a premium subscriber, you can gift this article for free
https://www.demo.com/demo-article/
Link copied to clipboard
You have reached the limit for gifting for this month
There was an error processing the request. Please try again later.
You have 10 article gifts to share each month
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Baker McKenzie Lawyers Discuss Global Dealmaking Risks as MFN Drug Pricing Policy Reshapes Pharmaceutical Transactions | 0 | 10 | 18-09-2026 |
| 2 | California’s Paramount Settlement Doesn’t Stop at Antitrust | 0 | 7.66 | 02-10-2026 |
| 3 | The convergence of IP, data, and AI regulation: managing assets for advantage | 0 | 7.35 | 30-09-2026 |
| 4 | Boies Schiller deepens AI bench as firms compete for specialist talent | 0 | 9.81 | 24-09-2026 |
| 5 | Beyond the headlines: PE isn’t the problem. The exit might be | 0 | 7.35 | 29-09-2026 |
| 6 | Rajah & Tann at 50: How Singapore gateway is driving global IP work | 0 | 11.94 | 17-09-2026 |
| 7 | Не догонять суд, а создавать адвокатский ИИ-контур | 0 | 14.65 | 18-09-2026 |
| 8 | The crucial things Anthropic’s jumbo ‘risk factors’ won’t tell you | 0 | 9.18 | 30-09-2026 |
| 9 | Opinion: Will Alberta's dual-practice model cut surgery wait times — or only for the rich? | 0 | 17.14 | 25-09-2026 |
| 10 | What’s In Your Lane? | 0 | 10 | 25-09-2026 |